Results 271 to 280 of about 905,763 (403)

Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry

open access: yesESC Heart Failure, EarlyView.
Among 668 with cardiogenic shock included in the multicentre prospective Altshock‐2 registry, 299 patients (44.8%) received pre‐admission beta‐blocker therapy. Previous beta‐blocker therapy influenced the early hemodynamic response to vasoactive drugs, but it was not associated with in‐hospital mortality.
Matteo Pagnesi   +21 more
wiley   +1 more source

Incidence and severity of ventricular arrhythmia in patients after repair of tetralogy of fallot.

open access: bronze, 1988
Junichiro Fukushige   +5 more
openalex   +2 more sources

Ventricular arrhythmias in long term survivors of orthotopic and heterotopic cardiac transplantation. [PDF]

open access: bronze, 1988
Dimitrios Alexopoulos   +5 more
openalex   +1 more source

Left ventricular decompression in paediatric veno‐arterial extracorporeal life support: Reviewing the evidence

open access: yesESC Heart Failure, EarlyView.
Abstract Veno‐arterial extracorporeal life support (VA ECLS) is crucial for neonatal and paediatric patients with severe circulatory collapse but may cause left ventricular (LV) overload, affecting myocardial recovery and causing complications. Evidence on optimal LV decompression strategies in paediatric patients remains limited.
Giacomo Veronese   +21 more
wiley   +1 more source

Short report: Hospitalization for new‐onset heart failure in survivors of hospitalized COVID‐19

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Previous studies have reported an incidence of new‐onset heart failure (HF) among COVID‐19 survivors ranging from 0.7 to 8.5 per 100 person‐years, but they relied on administrative data for outcome ascertainment. Given the public health implications, a more accurate characterization of the HF burden post‐COVID‐19 is important. Methods and
Vicente Corrales‐Medina   +6 more
wiley   +1 more source

Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology

open access: yesEuropean Journal of Heart Failure, EarlyView.
For most patients with chronic, progressive illnesses, maintaining good quality of life (QoL), with preserved functional capacity, is just as crucial as prolonging survival. Patients with heart failure (HF) experience much worse QoL and effort intolerance than both the general population and people with other chronic conditions, since they present a ...
Maurizio Volterrani   +21 more
wiley   +1 more source

Percutaneous Epicardial Ablation of Ventricular Arrhythmias Arising From the Left Ventricular Summit: Outcomes and Electrocardiogram Correlates of Success

open access: yesCirculation: Arrhythmia and Electrophysiology, 2015
P. Santangeli   +13 more
semanticscholar   +1 more source

New cardiovascular biomarkers in patients with advanced cancer – A prospective study comparing MR‐proADM, MR‐proANP, copeptin, high‐sensitivity troponin T and NT‐proBNP

open access: yesEuropean Journal of Heart Failure, EarlyView.
(A) Univariable receiver operating characteristic (ROC) curves for all biomarkers. (B) Kaplan–Meier curves for best cut‐point of mid‐regional pro‐adrenomedullin (MR‐proADM) for survival (n = 442). AUC, area under the curve; CI, confidence interval; HR, hazard ratio; hsTnT, high‐sensitivity troponin T; MR‐proANP, mid‐regional pro‐atrial natriuretic ...
Markus S. Anker   +18 more
wiley   +1 more source

A critical analysis of online patient-directed resources on catheter ablation for ventricular arrhythmias. [PDF]

open access: yesJ Arrhythm
Sood A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy